Comet Aktie 36082699 / CH0360826991
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
17.10.2025 06:30:13
|
Comet on track after nine months, Q3 results lower amid market uncertainty
|
Comet Holding AG
/ Key word(s): Quarterly / Interim Statement
Trading update third quarter 2025
Comet has published its trading update for Q3/25, reporting net sales of CHF 102.5 million. This represents a 9.4% decline (–3.9% at constant FX) compared to the same period last year when net sales were CHF 113.2 million. Additionally, the Q3/25 net sales decreased by 11.6% (–6.3% at constant FX) compared to CHF 115.9 million in Q2/25. For the first nine months of the year, Comet recorded net sales of CHF 329.6 million, showing a notable increase of 9.0% (+13.1% at constant FX) compared to the same period in the previous year when net sales were CHF 302.5 million. The decline in Q3/25 net sales was primarily due to lower business activity in the Plasma Control Technologies (PCT) division, influenced by market uncertainties. In addition, a weaker USD and tariffs also had an adverse impact on performance. Strength in the DRAM and Logic segments, driven by AI technologies, did not fully offset the still weak orders for consumer-related memory applications. In this segment, chip manufacturers continued to focus more on upgrades than on new production capacity. Despite these challenges, there are positive signs: higher memory pricing and, specific to Comet, the rebuilding of consignment stocks and increased orders toward the end of the quarter, all of which signal a potential uptick in memory market activity. Comet’s x-ray businesses, with greater exposure to traditional industries, continued to deliver solid performance in the aerospace, security, and defense sectors. However, challenges persisted in the automotive sector, with subdued consumer sentiment and moderating electric vehicle demand impacting production volumes, especially in Europe. In the PCT division, the radio-frequency generator (RFG) Synertia achieved multiple opportunities in the final qualification stages. With a strong pipeline of opportunities and successful engagement with customers, Comet is well-positioned for growth in the coming year. The IXS division is advancing with key semiconductor industry customers, as evidenced by a handful of purchase orders for the x-ray system CA20 from various customers and a growing number of engagements. In addition, the new technology used in CA20 was further validated through its participation in the JOINT3 Consortium led by Resonac which aims to accelerate the development of materials and equipment for panel-level advanced packaging. The division also secured several new orders for its Dragonfly software.
Outlook While demand for microchips for AI and high-performance computing applications remains strong, semiconductor sales in volume markets such as automotive and consumer electronics are experiencing ongoing weakness. Therefore, Comet does not foresee a rebound in sales volumes until year-end 2025. However, there are signs of recovery in the volume-driven memory segment, with growth expected to pick up in 2026. This recovery is likely to drive demand for wafer fabrication equipment and components. However, volatility in these markets is expected to persist. In this business environment, Comet remains focused on introducing new products to exceeding market growth and enhancing efficiency to improve its performance. Based on the above assumptions, Comet refines its guidance for net sales and EBITDA margin to the lower end of the range of CHF 460 million to CHF 500 million and 10.0% to 14.0% respectively.
-end-
Comet
End of Media Release |
| Language: | English |
| Company: | Comet Holding AG |
| Herrengasse 10 | |
| 3175 Flamatt | |
| Switzerland | |
| Phone: | +41 31 744 90 00 |
| E-mail: | info@comet.tech |
| Internet: | www.comet.tech |
| ISIN: | CH0360826991 |
| Valor: | 36082699 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2214614 |
| End of News | EQS News Service |
|
|
2214614 17.10.2025 CET/CEST
Nachrichten zu Comet Holding AG
|
07.11.25 |
Comet Aktie News: Anleger schicken Comet am Nachmittag ins Plus (finanzen.ch) | |
|
07.11.25 |
Comet Aktie News: Comet am Freitagmittag auf grünem Terrain (finanzen.ch) | |
|
07.11.25 |
Comet Aktie News: Comet gewinnt am Freitagvormittag an Boden (finanzen.ch) | |
|
03.11.25 |
SPI-Titel Comet-Aktie: So viel hätten Anleger an einem Comet-Investment von vor 5 Jahren verdient (finanzen.ch) | |
|
03.11.25 |
Gewinne in Zürich: SPI steigt zum Start des Montagshandels (finanzen.ch) | |
|
27.10.25 |
SPI-Wert Comet-Aktie: So viel Gewinn hätte ein Comet-Investment von vor 3 Jahren abgeworfen (finanzen.ch) | |
|
24.10.25 |
Starker Wochentag in Zürich: SPI zum Start des Freitagshandels mit grünem Vorzeichen (finanzen.ch) | |
|
20.10.25 |
SPI-Papier Comet-Aktie: So viel Verlust hätte ein Investment in Comet von vor einem Jahr bedeutet (finanzen.ch) |
Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI geht wenig bewegt ins Wochenende -- DAX schliesslich mit Abgaben -- Wall Street beenden Handel uneins -- Asiens Börsen letztlich schwächerDer heimische Aktienmarkt tendierte am Freitag seitwärts, während der deutsche Aktienmarkt sich abwärts bewegte. An der Wall Street ging es am Freitag in unterschiedliche Richtungen. An den Märkten in Fernost ging es zum Wochenende nach unten.


